Apellis Pharmaceuticals Inc logo

Apellis Pharmaceuticals Inc (APLS)

$40.11

Apellis Pharmaceuticals Inc (APLS) Share Price Forecast
Currently 23 wall-street analysts regularly analyze the financials of Apellis Pharmaceuticals Inc on a frequent basis to provide recommendations along with target share price. 23 analysts offering 12-month price forecasts for Apellis Pharmaceuticals Inc (APLS) have a share price target of $77.44. This median of share price forecast represents a 93.07% upside from the latest price of $40.11 as on 04.06.24.

Apellis Pharmaceuticals Inc (APLS) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Apellis Pharmaceuticals Inc (APLS) share price will touch around $77.44 in next 12-months.
Apellis Pharmaceuticals Inc (APLS) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Apellis Pharmaceuticals Inc's share price and its median forecast price. As on 04.06.24, the difference is -42.1%

Apellis Pharmaceuticals Inc (APLS): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Apellis Pharmaceuticals Inc (APLS) Share Price : Analyst Recommendation
Based on 23 analysts tracking and researching Apellis Pharmaceuticals Inc (APLS) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
10
10
10
Outperform
8
9
9
Hold
5
4
4
Underperform
0
0
0
Sell
0
0
0
Apellis Pharmaceuticals Inc (APLS) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Apellis Pharmaceuticals Inc (APLS) is $77.44, offered by 23 analysts offering 12-month price forecasts.

Apellis Pharmaceuticals Inc (APLS) has a maximum of 0.93 upside potential, based on 23 analysts offering 12-month price forecasts.

Based on 23 analysts tracking and researching Apellis Pharmaceuticals Inc (APLS), 82.61% have a buy recommendation. Remaining 17.39% have either sell or hold recommendations.

The latest share price of Apellis Pharmaceuticals Inc (APLS) is $40.11 as of 04/06/2024.

19 of total 23 analysts offering stock ratings for Apellis Pharmaceuticals Inc APLS have recommended buy rating.